New Single-Dose flu drug shows promise in kids trial
Disease control
Completed
This study tested a new flu medicine called ZX-7101A in 169 children aged 2 to 11. The medicine was given as a single oral dose, and researchers compared it to a standard 5-day treatment (oseltamivir). The main goal was to check safety and how well it relieved flu symptoms. The t…
Phase: PHASE3 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC